These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 12613095)
21. Second generation antipsychotics--aripiprazole revisited. Med Lett Drugs Ther; 2005 Oct; 47(1219):81-2. PubMed ID: 16247339 [TBL] [Abstract][Full Text] [Related]
22. Placental transfer of aripiprazole. Nguyen T; Teoh S; Hackett LP; Ilett K Aust N Z J Psychiatry; 2011 Jun; 45(6):500-1. PubMed ID: 21413838 [No Abstract] [Full Text] [Related]
27. Effectiveness of intramuscular aripiprazole injection in patients with catatonia: report on three cases. Voros V; Kovacs A; Herold R; Osvath P; Simon M; Fekete S; Tenyi T Pharmacopsychiatry; 2009 Nov; 42(6):286-7. PubMed ID: 19924590 [No Abstract] [Full Text] [Related]
28. [Clinical observations with aripiprazole in schizophrenia]. Gaszner P Neuropsychopharmacol Hung; 2006 Mar; 8(1):29-32. PubMed ID: 16841563 [TBL] [Abstract][Full Text] [Related]
29. Perinatal use of aripiprazole: a case report. Watanabe N; Kasahara M; Sugibayashi R; Nakamura T; Nakajima K; Watanabe O; Murashima A J Clin Psychopharmacol; 2011 Jun; 31(3):377-9. PubMed ID: 21532364 [No Abstract] [Full Text] [Related]
30. Aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist. Burke MJ; Lincoln J Ann Clin Psychiatry; 2006; 18(2):129-30. PubMed ID: 16754419 [No Abstract] [Full Text] [Related]
31. Trial of aripiprazole in the treatment of first-episode schizophrenia. Lee HY; Ham BJ; Kang RH; Paik JW; Hahn SW; Lee MS; Lee MS Psychiatry Clin Neurosci; 2010 Feb; 64(1):38-43. PubMed ID: 20416024 [TBL] [Abstract][Full Text] [Related]
32. Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia. Gründer G; Kungel M; Ebrecht M; Göröcs T; Modell S Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S21-5. PubMed ID: 16508892 [TBL] [Abstract][Full Text] [Related]
34. Aripiprazole in adolescents with schizophrenia: profile report. Sanford M; Keating GM CNS Drugs; 2008; 22(6):529-30. PubMed ID: 18484794 [No Abstract] [Full Text] [Related]
35. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia". Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377 [No Abstract] [Full Text] [Related]
36. Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma. Freeman B; Levy W; Gorman JM J Psychiatr Pract; 2007 Mar; 13(2):120-4. PubMed ID: 17414690 [No Abstract] [Full Text] [Related]
39. Extensive weight loss in a patient with schizophrenia after switching from olanzapine to aripiprazole. A case report. Luebbe G; Kropp S; Harms E; Ziegenbein M Pharmacopsychiatry; 2006 Mar; 39(2):76. PubMed ID: 16555168 [No Abstract] [Full Text] [Related]
40. Combined use of ECT with aripiprazole. Lopez-Garcia P; Chiclana C; Gonzalez R World J Biol Psychiatry; 2009; 10(4 Pt 3):942-3. PubMed ID: 17853257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]